Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Urinary Bladder Urothelial Carcinoma”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Testing effectiveness (Phase 2)Study completedNCT00035061
What this trial is testing

Trial of ALIMTA (Pemetrexed) in Locally Advanced or Metastatic Recurrent Transitional Cell Carcinoma of the Urothelium

Who this might be right for
Urologic NeoplasmsMetastases, Neoplasm
Eli Lilly and Company
Testing effectiveness (Phase 2)Study completedNCT01599013
What this trial is testing

JAVLOR Association Study in CDDP-unfit Patients With Advanced Transitional Cell Carcinoma: Gemcitabine Versus Carboplatin

Who this might be right for
Bladder Transitional Cell Carcinoma Stage IV
Pierre Fabre Medicament 69
Early research (Phase 1)Study completedNCT03404791
What this trial is testing

TAR-200 in Participants With Muscle-Invasive Urothelial Carcinoma of the Bladder Who Are Ineligible for or Refuse Cisplatin-based Chemotherapy and Who Are Unfit for Radical Cystectomy

Who this might be right for
Urinary Bladder Neoplasms
Janssen Research & Development, LLC 35
Not applicableEnded earlyNCT05699135
What this trial is testing

Learn About the Effect of Avelumab First-Line Maintenance in Canadian People With Advanced Bladder Cancer

Who this might be right for
Urinary Bladder NeoplasmsBladder CancerBladder Tumors+1 more
Pfizer 150
Not applicableUnknownNCT06550947
What this trial is testing

ALDOA Expression in Bladder Urothelial Carcinoma

Who this might be right for
Bladder Urothelial Carcinoma
Assiut University 50
Testing effectiveness (Phase 2)Looking for participantsNCT06257017
What this trial is testing

Surveillance of the Genetic Signature in Circulating Tumor DNA for Guiding Adjuvant Chemotherapy in Urothelial Carcinoma

Who this might be right for
Muscle Invasive Bladder Urothelial CarcinomaMuscle-Invasive Bladder Carcinoma
Yung NA 20
Not applicableActive Not RecruitingNCT00567684
What this trial is testing

Computed Tomography Urography (CTU) vs Intravenous Urography (IVU) on Patients at Risk of Urothelial Tumors

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 133
Not applicableStudy completedNCT00095589
What this trial is testing

Microsatellite Analysis of Urinary Sediment in Detecting Bladder Cancer

Who this might be right for
Bladder Cancer
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins 125
Large-scale testing (Phase 3)WithdrawnNCT07313891
What this trial is testing

Adjuvant NDV-01 (Sustained-release Gemcitabine-docetaxel) for the Treatment of Intermediate Risk NMIBC Following TURBT

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer Superficial (Non-Invasive)Bladder (Urothelial, Transitional Cell) CancerUrothelial Carcinoma Bladder+1 more
Relmada Therapeutics, Inc.
Not applicableLooking for participantsNCT07728474
What this trial is testing

LCS103 Herbal Formula for Secondary Prevention of Non-Muscle Invasive Urothelial Carcinoma of the Bladder

Who this might be right for
Non-muscle Invasive Bladder Cancer (NMIBC)
LifeBiotic Medical Research Ltd. 60
Testing effectiveness (Phase 2)Looking for participantsNCT06417190
What this trial is testing

Bladder Preservation for Patients With Muscle Invasive Bladder Cancer (MIBC) With Variant Histology

Who this might be right for
Muscle-Invasive Bladder CarcinomaTumor
Leslie Ballas 20
Testing effectiveness (Phase 2)Ended earlyNCT00479089
What this trial is testing

Iressa and Taxotere Study in Patients With Metastatic Urothelial Cancer

Who this might be right for
Bladder Cancer
M.D. Anderson Cancer Center 50
Testing effectiveness (Phase 2)Ended earlyNCT04851834
What this trial is testing

NTX-301 Monotherapy in Advanced Solid Tumours and in Combination With Platinum-based Chemotherapy in Advanced Ovarian & Bladder Cancer and in Combination With Temozolomide in High-grade Glioma

Who this might be right for
Advanced Solid TumorPlatinum-Resistant Ovarian CancerPlatinum-Resistant Urothelial Carcinoma+1 more
Xennials Therapeutics Australia Pty Ltd 12
Testing effectiveness (Phase 2)Looking for participantsNCT07421700
What this trial is testing

Symbiotic-GU-06: A Study to Learn About PF-08634404 Alone or In Combination With Enfortumab Vedotin in Urothelial Cancer

Who this might be right for
Urothelial CancerAdvanced/Metastatic Urothelial CancerUrothelial Carcinoma
Pfizer 132
Not applicableEnrolling By InvitationNCT07091565
What this trial is testing

Supporting Sexual Recovery in Women With Bladder Cancer

Who this might be right for
Bladder CancerCystectomyFemale Sexual Dysfunction
King's College London 60
Testing effectiveness (Phase 2)Study completedNCT00471536
What this trial is testing

Pazopanib in Treating Patients With Metastatic Urothelial Cancer

Who this might be right for
Distal Urethral CancerProximal Urethral CancerRecurrent Bladder Cancer+5 more
National Cancer Institute (NCI) 19
Testing effectiveness (Phase 2)Looking for participantsNCT07019220
What this trial is testing

Chemoablation for Low-Grade Bladder Cancer

Who this might be right for
Bladder (Urothelial, Transitional Cell) Cancer
Ekaterina Laukhtina 47
Large-scale testing (Phase 3)Ended earlyNCT00003824
What this trial is testing

S9809, Ciprofloxacin Compared With Cephalexin in Treating Patients With Bladder Cancer

Who this might be right for
Bladder Cancer
SWOG Cancer Research Network 114
Early research (Phase 1)UnknownNCT04432857
What this trial is testing

AN0025 and Pembrolizumab Combination in Advanced Solid Tumors

Who this might be right for
Triple-negative Breast CancerNSCLC, Squamous or Non-SquamousUrothelial Carcinoma of the Bladder+2 more
Adlai Nortye Biopharma Co., Ltd. 63
Testing effectiveness (Phase 2)Study completedNCT03430895
What this trial is testing

Evaluating Immune Therapy, Durvalumab (MEDI4736) With Tremelimumab for Metastatic, Non-transitional Cell Carcinoma of the Urinary Tract

Who this might be right for
Non-Transitional Cell Carcinoma of the Urothelial TractSmall Cell of the BladderAdenocarcinoma of the Bladder+2 more
Memorial Sloan Kettering Cancer Center 15
Next Page